{"id":67709,"date":"2022-11-29T13:03:32","date_gmt":"2022-11-29T12:03:32","guid":{"rendered":"http:\/\/www.veeva.com\/eu\/?post_type=resources&#038;p=67709"},"modified":"2026-06-18T18:08:31","modified_gmt":"2026-06-18T16:08:31","slug":"veeva-pulse-shows-europe-hcp-access-averages-52-with-largest-growth-in-content-driven-digital-engagement-worldwide","status":"publish","type":"resources","link":"https:\/\/www.veeva.com\/eu\/resources\/veeva-pulse-shows-europe-hcp-access-averages-52-with-largest-growth-in-content-driven-digital-engagement-worldwide\/","title":{"rendered":"³Ô¹Ï±¬ÁÏ Pulse Shows Europe HCP Access Averages 52% with Largest Growth in Content-Driven Digital Engagement Worldwide"},"content":{"rendered":"<p align=\"center\"><em>Access is selective as most HCPs meet with three or less companies<\/em><\/p>\n<p><strong>BARCELONA, Spain &#8211; 29 Nov. 2022 \u2014<\/strong> <a href=\"\/eu\/\">³Ô¹Ï±¬ÁÏ Systems<\/a> (NYSE: VEEV) today released the first view of healthcare professional (HCP) access across key European markets from the <a href=\"\/eu\/pharma-hcp-360-trends-report\/\">³Ô¹Ï±¬ÁÏ Pulse Field Trends Report<\/a>, the largest global industry benchmark of its kind on HCP engagement. Data shows European HCP access now averages 52% across countries, driven by the increasing use of video meetings and content to complement in-person visits. <\/p>\n<p>These new findings underscore the impact of digital as a third of accessible HCPs now engage via video along with in-person, and the addition of video is shown to increase duration and frequency of meetings for more meaningful engagement. This combination of reach, channel preference, and effectiveness is even more critical as 65% of accessible HCPs limit engagement to three companies or less.<\/p>\n<p>Latest ³Ô¹Ï±¬ÁÏ Pulse data show combination of video and in-person meetings maximize field access:<\/p>\n<p><a href=\"https:\/\/www.veeva.com\/eu\/wp-content\/uploads\/2022\/11\/Europe_Field-Activity-by-Country.png\"><img decoding=\"async\" src=\"https:\/\/www.veeva.com\/eu\/wp-content\/uploads\/2022\/11\/Europe_Field-Activity-by-Country.png\" alt=\"Europe_Field Activity by Country\" width=\"90%\" class=\"aligncenter size-full wp-image-67808\" \/><\/a><\/p>\n<ul>\n<li><strong>Post-pandemic HCP access is higher than expected:<\/strong> Overall HCP accessibility is now at 52%. Of those HCPs, approximately one-third engage with reps using video meetings. <\/li>\n<li><strong>Content use rises with growth of video meetings:<\/strong> Europe saw the most dramatic increase in content utilization globally. Content usage in video meetings increased by 10%, while in-person content usage increased by 7%. <\/li>\n<li><strong>HCPs are more selective:<\/strong> 65% of accessible HCPs limit meetings to three or fewer companies. In the U.K. nearly all accessible HCPs (94%) only meet with less than three companies. <\/li>\n<li><strong>Country-by-country engagement varies widely:<\/strong> For instance, despite nearly identical weekly total activity for France and the U.K., the in-person mix in France was more than double that of the U.K. which has regulated in-person restrictions. The U.K. filled this gap through a greater mix of email and video.<\/li>\n<\/ul>\n<p>\u201c³Ô¹Ï±¬ÁÏ Pulse Field Trends Report gives the most extensive view ever into HCP access and channel effectiveness industrywide so teams can definitively benchmark what actions they can take to strengthen engagement and drive better outcomes,\u201d said Aaron Bean, vice president of ³Ô¹Ï±¬ÁÏ business consulting, Europe. \u201cSeeing how access has changed and HCPs are very selective of meetings, the most successful companies are optimizing digital channels to both increase reach and deliver relevant, impactful content to maximize the quality of each engagement.\u201d <\/p>\n<p><strong>About the ³Ô¹Ï±¬ÁÏ Pulse Field Trends Report<\/strong><\/br><br \/>\nAnalyzing over 600 million HCP interactions and activities annually from more than 80% of commercial biopharma field teams worldwide, the <a href=\"\/eu\/pharma-biotech-field-trends\/\">³Ô¹Ï±¬ÁÏ Pulse Field Trends Report<\/a> is the largest industry benchmark of its kind on HCP engagement. The analysis compiles real-time transactional data recorded in <a href=\"\/eu\/products\/crm-suite\/\">³Ô¹Ï±¬ÁÏ CRM<\/a> globally and from European markets including the United Kingdom, Italy, Germany, France, and Spain. Indexed by ³Ô¹Ï±¬ÁÏ quarterly, the data will help companies effectively and accurately benchmark performance to set the right, actionable goals for continued growth and impact. <\/p>\n<p><strong>Additional Information<\/strong><\/br><br \/>\nTo download a copy of the ³Ô¹Ï±¬ÁÏ Pulse Field Trends Report, visit: <a href=\"\/eu\/pharma-biotech-field-trends\/\">veeva.com\/eu\/FieldTrends<\/a><br \/>\nLearn more about ³Ô¹Ï±¬ÁÏ Business Consulting: <a href=\"\/eu\/services\/business-consulting-services\/\">veeva.com\/eu\/BusinessConsulting<\/a><br \/>\nConnect with ³Ô¹Ï±¬ÁÏ on LinkedIn: <a href=\"https:\/\/www.linkedin.com\/company\/veeva-systems\" target=\"_blank\" rel=\"noopener noreferrer\">linkedin.com\/company\/veeva-systems<\/a>\n<\/p>\n<p><strong>About ³Ô¹Ï±¬ÁÏ Systems<\/strong><br \/>\n³Ô¹Ï±¬ÁÏ is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ serves more than 1,000 customers, ranging from the world\u2019s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, ³Ô¹Ï±¬ÁÏ is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit <a href=\"\/eu\/\">veeva.com\/eu<\/a>.<\/p>\n<p>###<\/p>\n<p><strong>Contact:<\/strong><\/p>\n<p>Jeremy Whittaker<br \/>\n³Ô¹Ï±¬ÁÏ Systems<br \/>\n+49 6950955486<br \/>\n<a href=\"mailto:jeremy.whittaker@veeva.com\">jeremy.whittaker@veeva.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Access is selective as most HCPs meet with three or less companies.<\/p>\n","protected":false},"featured_media":67760,"parent":0,"template":"","class_list":["post-67709","resources","type-resources","status-publish","has-post-thumbnail","hentry","resource-html-content-yes","resource-area-20-commercial","resource-product-20-crm","resource-type-news-press-release","resource-type-press-release"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/67709"}],"collection":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/types\/resources"}],"version-history":[{"count":1,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/67709\/revisions"}],"predecessor-version":[{"id":67758,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/67709\/revisions\/67758"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media\/67760"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media?parent=67709"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}